AstraZeneca
AZN
AZN
518 hedge funds and large institutions have $13.9B invested in AstraZeneca in 2018 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 166 increasing their positions, 167 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $13.4B → $13.9B (+$525M)
0.94% more ownership
Funds ownership: 30.41% → 31.35% (+0.94%)
1% less repeat investments, than reductions
Existing positions increased: 166 | Existing positions reduced: 167
Holders
518
Holding in Top 10
7
Calls
$171M
Puts
$118M
Top Buyers
| 1 | +$192M | |
| 2 | +$87.6M | |
| 3 | +$79M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$68.6M |
| 5 |
YCMGA
York Capital Management Global Advisors
New York
|
+$56M |
Top Sellers
| 1 | -$101M | |
| 2 | -$81.8M | |
| 3 | -$70.2M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
-$69.3M |
| 5 |
HP
Holowesko Partners
Nassau,
Bahamas
|
-$50.9M |